Evidence map›Paper›PMID 33782002›Full record

ArticleAntimicrobial agents and chemotherapy2021

Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"

A-G Märtson, J M Boonstra, I Sandaradura, J G W Kosterink, T S van der Werf, D J E Marriott, J G Zijlstra, D J Touw, J W C Alffenaar

Open access · greenAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

A-G Märtson *University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands.
J M Boonstra *University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands.
I SandaraduraThe University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia.ORCID 0000-0002-9457-8262
J G W KosterinkUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands.
T S van der WerfUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, the Netherlands.
D J E MarriottSt. Vincent's Clinical School, University of New South Wales, Kensington, NSW, Australia.
J G ZijlstraUniversity of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen, the Netherlands.
D J TouwUniversity of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, the Netherlands.
J W C AlffenaarThe University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia johannes.alffenaar@sydney.edu.au.ORCID 0000-0001-6703-0288
University Medical Center Groningen · NLThe University of Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Candidiasis, InvasiveFluconazoleCritical IllnessHumansFluconazole

Identifiers

PMID33782002
PMCPMC8316007
OpenAlexW3140220309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.